LATEST TRENDS IN DESIGN OF PIVOTAL PHASE III CLINICAL TRIALS FOR PERIPHERAL T-CELL LYMPHOMA

被引:0
|
作者
Aggarwal, S. [1 ]
Kumar, S. [2 ]
Topaloglu, H. [1 ]
机构
[1] NOVEL Hlth Strategies, Chevy Chase, MD USA
[2] Inst Global Policy Res, Washington, DC USA
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PRM185
引用
下载
收藏
页码:A104 / A104
页数:1
相关论文
共 50 条
  • [1] LATEST TRENDS IN DESIGN OF PIVOTAL PHASE III CLINICAL TRIALS FOR HEMOPHILIA A AND B
    Aggarwal, S.
    Kumar, S.
    Topaloglu, H.
    VALUE IN HEALTH, 2016, 19 (03) : A103 - A103
  • [2] LATEST TRENDS IN DESIGN OF PIVOTAL PHASE III CLINICAL TRIALS FOR PARTIAL ONSET OF SEIZURES
    Aggarwal, S.
    Kumar, S.
    Topaloglu, H.
    VALUE IN HEALTH, 2016, 19 (03) : A103 - A103
  • [3] TRENDS IN DESIGN OF PIVOTAL PHASE III CLINICAL TRIALS FOR CLUSTER HEADACHE DISORDER
    Aggarwal, S.
    Kumar, S.
    Topaloglu, H.
    VALUE IN HEALTH, 2016, 19 (03) : A104 - A104
  • [4] LATEST TRENDS IN DESIGN OF PIVOTAL CLINICAL TRIALS FOR HUNTINGTON'S DISEASE
    Aggarwal, S.
    Kumar, S.
    Topaloglu, H.
    VALUE IN HEALTH, 2016, 19 (03) : A77 - A77
  • [5] Results of a phase III clinical trial: CHOP versus CMED in peripheral T-cell lymphoma unspecified
    Aviles, Agustin
    Castaneda, Claudia
    Neri, Natividad
    Cleto, Sergio
    Talavera, Alejandra
    Gonzalez, Martha
    Huerta-Guzman, Judith
    Nambo, M. Jesus
    MEDICAL ONCOLOGY, 2008, 25 (03) : 360 - 364
  • [6] Results of a phase III clinical trial: CHOP versus CMED in peripheral T-cell lymphoma unspecified
    Agustin Avilés
    Claudia Castañeda
    Natividad Neri
    Sergio Cleto
    Alejandra Talavera
    Martha González
    Judith Huerta-Guzmán
    M. Jesús Nambo
    Medical Oncology, 2008, 25 : 360 - 364
  • [7] Outcomes of patients with peripheral T-cell lymphoma: a subset analysis of the NCIC Clinical Trials Group LY.12 Phase III clinical trial
    Hay, A. E.
    Savage, K. J.
    Crump, M.
    Reiman, A.
    Meyer, R. M.
    Good, D.
    LeBrun, D. P.
    Kuruvilla, J.
    Djurfeldt, M. S.
    Chen, B. E.
    Shepherd, L. E.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 : 53 - 54
  • [8] TRENDS IN DESIGN OF PIVOTAL PHASE III CLINICAL TRIALS FOR ALPHA 1 ANTI TRYPSIN DEFICIENCY DISORDER
    Aggarwal, S.
    Kumar, S.
    Topaloglu, H.
    VALUE IN HEALTH, 2016, 19 (03) : A102 - A103
  • [9] Primary cutaneous peripheral T-cell lymphoma, unspecified, with an indolent clinical course: a distinct peripheral T-cell lymphoma?
    Ryan, A.
    Hayes, B.
    Robson, A.
    Sheahan, K.
    Collins, P.
    BRITISH JOURNAL OF DERMATOLOGY, 2009, 161 : 57 - 57
  • [10] Primary cutaneous peripheral T-cell lymphoma, unspecified with an indolent clinical course: a distinct peripheral T-cell lymphoma?
    Ryan, A. J. A.
    Robson, A.
    Hayes, B. D.
    Sheahan, K.
    Collins, P.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2010, 35 (08) : 892 - 896